Pancuronium and Scopolamine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pancuronium (pancuronium bromide) and Scopolamine (scopolamine). Common drug interactions include multi-organ failure among females and injury among males.

The phase IV clinical study analyzes what interactions people have when they take Pancuronium and Scopolamine. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Pancuronium?

Pancuronium has active ingredients of pancuronium bromide. eHealthMe is studying from 1,328 Pancuronium users. Check the latest studies of Pancuronium.

What is Scopolamine?

Scopolamine has active ingredients of scopolamine. eHealthMe is studying from 4,945 Scopolamine users. Check the latest studies of Scopolamine.

On Jul, 16, 2026

17 people who take Pancuronium and Scopolamine together, and have interactions are studied.

Pancuronium and Scopolamine drug interactions.

What are the common drug interactions of Pancuronium and Scopolamine, by gender? *:

female:

Multi-organ failure (multisystem organ failure)
Renal failure (kidney dysfunction)
Adrenal cortex necrosis (death adrenal cortex tissue)
Adult respiratory distress syndrome (type of lung (pulmonary) failure)
Duodenal ulcer perforation (untreated ulcer can burn through the wall of the stomach)
Hepatic necrosis (large portions of liver die off due to severe liver disease)
Pyrexia (fever)
Staphylococcal infection (an infection with staphylococcus bacteria)
White blood cell count increased
Bradycardia (abnormally slow heart action)

male:

Injury
Pain
Emotional distress
Multi-organ failure (multisystem organ failure)
Stress
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
Cardiac arrest
Cardiac disorder
Cardiogenic shock (inadequate circulation of blood)

What are the common drug interactions of Pancuronium and Scopolamine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Cardiac failure congestive
Pulmonary oedema (fluid accumulation in the lungs)
Renal failure chronic (long lasting kidney dysfunction)

50-59:

Bradycardia (abnormally slow heart action)
Injury
Pain
Renal failure (kidney dysfunction)
Acute circulatory failure (shock)
Anaphylactic reaction (serious allergic reaction)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Cardiogenic shock (inadequate circulation of blood)
Death

60+:

Renal failure (kidney dysfunction)
Multi-organ failure (multisystem organ failure)
Pain
Pyrexia (fever)
Renal injury (kidney injury)
Staphylococcal infection (an infection with staphylococcus bacteria)
White blood cell count increased
Bradycardia (abnormally slow heart action)
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Death

What are the existing conditions these people have? *

Anaesthesia: 5 people, 29.41%
Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 1 person, 5.88%
Sedation: 1 person, 5.88%
Memory Loss: 1 person, 5.88%
Atrioventricular Block Complete (heart block complete): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Pancuronium and Scopolamine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously